FindTrial
Sign In

Absorb BVS

DEVICE7 trials

Sponsors

Abbott Medical Devices, Uppsala University, J.J. Wykrzykowska

Conditions

Acute Coronary Syndrome (ACS)Arterial Occlusive LesionsArteriosclerosisCardiovascular DiseaseCardiovascular DiseasesCoronary Artery DiseaseCoronary Artery StenosisCoronary Bifurcation Lesions

Unknown Phase

ABSORB EXTEND Clinical Investigation
CompletedNCT01023789
Abbott Medical DevicesCardiovascular Disease, Coronary Artery Disease, Coronary Artery Stenosis +3
Start: 2010-01-31End: 2016-10-31Updated: 2018-02-14
ABSORB III Randomized Controlled Trial (RCT)
CompletedNCT01751906
Abbott Medical DevicesCoronary Artery Disease, Coronary Artery Stenosis, Coronary Disease +1
Start: 2012-12-31End: 2020-10-31Updated: 2023-10-11
To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated Vessels
CompletedNCT01977534
Abbott Medical DevicesCoronary Artery Disease, Coronary Disease, Coronary Restenosis
Start: 2014-01-31End: 2018-10-31Updated: 2018-12-17
PROSPECT II & PROSPECT ABSORB - an Integrated Natural History Study and Randomized Trial.
CompletedNCT02171065
Uppsala UniversityAcute Coronary Syndrome (ACS)
Start: 2014-06-30End: 2020-05-31Updated: 2021-08-10
Absorb IV Randomized Controlled Trial
CompletedNCT02173379
Abbott Medical DevicesCoronary Artery Disease, Coronary Artery Stenosis, Coronary Disease +1
Start: 2014-07-31End: 2022-04-06Updated: 2023-10-30
Bifurcation ABSORB OCT Trial
NCT02928198
J.J. WykrzykowskaArterial Occlusive Lesions, Arteriosclerosis, Cardiovascular Diseases +7
Start: 2016-06-30End: 2020-03-31Updated: 2018-01-17
ABSORB Post-Approval Clinical Study
WithdrawnNCT02943616
Abbott Medical DevicesIschemic Heart Disease
Start: 2017-08-31End: 2021-01-31Updated: 2018-01-11

Related Papers

Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy
Circulation2025-06-233 citations
Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques: A PROSPECT II Substudy.
2025-06-018 citations
Relationships of hsCRP to High-Risk Vulnerable Plaque After NSTEMI: Insights From the PROSPECT II Trial.
2025-04-232 citations
Association Between Physiological Significance and Vulnerable Plaque Characteristics in Patients With Myocardial Infarction: A Prospect II Substudy.
2025-02-242 citations
Early and Late Outcomes With the Absorb Bioresorbable Vascular Scaffold: Final Report From the ABSORB Clinical Trial Program.
2025-01-018 citations
Impact of Lipidic Plaque on In-Stent and Stent Edge–Related Events After PCI in Myocardial Infarction: A PROSPECT II Substudy
Circulation Cardiovascular Interventions2024-09-257 citations
5-Year Outcomes After Bioresorbable Coronary Scaffolds Implanted With Improved Technique
Journal of the American College of Cardiology2023-05-1747 citations
Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II
Circulation2022-12-1616 citations
Anatomic and Hemodynamic Plaque Characteristics for Subsequent Coronary Events
Frontiers in Cardiovascular Medicine2022-05-2314 citations
Intravascular ultrasound predictors of long-term outcomes following ABSORB bioresorbable scaffold implantation: A pooled analysis of the ABSORB III and ABSORB Japan trials.
2021-04-214 citations
Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study.
2021-03-01317 citations
Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque.
2020-10-15151 citations
Time-Varying Outcomes With the Absorb Bioresorbable Vascular Scaffold During 5-Year Follow-up: A Systematic Meta-analysis and Individual Patient Data Pooled Study.
2019-12-0168 citations
Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption
Circulation2019-09-2587 citations
Three‐year clinical outcomes of patients treated with everolimus‐eluting bioresorbable vascular scaffolds: Final results of the ABSORB EXTEND trial
Catheterization and Cardiovascular Interventions2018-10-0411 citations
Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial.
2018-09-2578 citations
Neoatherosclerosis 5 Years After Bioresorbable Vascular Scaffold Implantation.
2018-05-0131 citations
3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial.
2017-10-31176 citations
Three-Year Outcomes With the Absorb Bioresorbable Scaffold: Individual-Patient-Data Meta-Analysis From the ABSORB Randomized Trials.
2017-10-31119 citations
Effect of Technique on Outcomes Following Bioresorbable Vascular Scaffold Implantation: Analysis From the ABSORB Trials.
2017-10-31103 citations

10 more papers not shown